Current Signal Transduction Therapy


Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:13   Issue: 2
Pp: 81-81
Tao Jiang
DOI: 10.2174/157436241302180919120200

Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction free to download

Volume:13   Issue: 2
Pp: 82-82
Sisir Nandi
DOI: 10.2174/157436241302180919120338

Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads

Volume:13   Issue: 2
Pp: 83-104
Sisir Nandi*, Mohd Salman, Ankita Sharma and Mohit Kumar
DOI: 10.2174/1574888X13666180301124935

Integrin Antagonists: A Special Emphasis on Structural Requirements of N-benzoyl-L-biphenylalanines as α4β7 and α4β1 Antagonists

Volume:13   Issue: 2
Pp: 105-118
Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen and Tarun Jha*
DOI: 10.2174/1574888X13666180301123106

Application of Chemoinformatic Tools for the Design of Novel Molecules as anti-Parkinsonian Agents

Volume:13   Issue: 2
Pp: 119-128
Ashis Nandy* and Indrani Adhikari*
DOI: 10.2174/1574362413666180221114441

Therapeutic Molecules for Fumigating Inflammatory Tumor Environment

Volume:13   Issue: 2
Pp: 129-152
Adhikesavan Harikrishnan and Vijaykumar Veena*
DOI: 10.2174/1574362413666180402145336

Chimeric Antigen Receptors; Their Current and Futuristic Scope

Volume:13   Issue: 2
Pp: 153-158
Preeti Sharma*, Pradeep Kumar and Rachna Sharma
DOI: 10.2174/1574362413666180517085528

Comparison of Surface Electromyogram Signal for Prosthetic Applications

Volume:13   Issue: 2
Pp: 168-172
Karan Veer* and Renu Vig
DOI: 10.2174/1574362413666180202163305

Acknowledgements to Reviewers free to download

Volume:13   Issue: 2
Pp: 173-173

DOI: 10.2174/157436241302180919144000